Centene Stock News

Centene Corporation (NYSE:CNC)’s traded shares stood at 2.47 million during the latest session, with the company’s beta value hitting 0.51. At the last check today, the stock’s price was $78.92, to imply an increase of 5.41% or $4.05 in intraday trading. The CNC share’s 52-week high remains $77.64, putting it 1.62% up since that peak … Centene Corporation (NYSE: CNC) Is A Good Bet For Risk-Tolerant Investors Read More »

Kansas AG Derek Schmidt reached a settlement with pharmacy benefit manager Centene Corp. and its subsidiaries (collectively Centene) to resolve allegations that it overbilled the states Medicaid program... By: Cozen O''Connor

NEW YORK , Dec. 10, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MRNA, NVDA, PFE, CHWY, and CNC. Full story available on Benzinga.com

Shares of Centene Corp. CNC, +1.34% rose 1.3% in premarket trading Friday, after the health care company provided a 2022 revenue outlook that was above expectations. The company also said it was evalu

Cigna (CI) announces that it will offer affordable MA plans in two new counties of Florida. Concurrently, CI includes HCA Healthcare to provide a boost to its provider network.

Humana (HUM) forges an alliance with the Loudoun Medical Group to boost its Medicare Advantage portfolio.

Cigna (CI) announces that it will offer affordable MA plans in two new counties of Florida. Concurrently, CI includes HCA Healthcare to provide a boost to its provider network.

UnitedHealth's (UNH) 2022 bottom line estimates are below the Zacks Consensus Estimate, may be due to an uptick in insurance claims triggered by the coronavirus pandemic.

Centene (CNC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Centene (CNC) reported earnings 30 days ago. What's next for the stock?

Humana (HUM) expands the value-based agreement with Hutchinson Clinic in a bid to provide enhanced healthcare services to its MA members in central Kansas.

Centene Corporation with ticker code (CNC) now have 19 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 94 and 70 calculating the mean target price we have 83.53. Now with the previous closing price of 73.01 this is indicating there is a potential upside of 14.4%. The 50 day MA is 67.53 while the 200 day moving average is 66.78. The market capitalisation for the company is $43,226m. Find out more information at: /> [stock_market_widget type="chart" symbol="CNC" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children''s health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs.

"Mad Money" host Jim Cramer on Monday laid out his strategy for investing amid a market rotation out of winning technology stocks.

Jim Cramer says he likes Morgan Stanley and health insurer Centene amid market rotation

THE takeover of GP practices in London by US health insurance giant Centene Corporation will be subject of a judicial review in early 2022 after more than £70,000 has been raised by the public to fund the case, Unite the union said yesterday. Campaigners say that the review is vital because of the lack of [] The post US takeover of GP surgeries subject to Judicial Review appeared first on Workers Revolutionary Party .